Provided by Tiger Fintech (Singapore) Pte. Ltd.

QT IMAGING

0.3951
+0.0000
Volume:- -
Turnover:- -
Market Cap:8.62M
PE:-0.86
High:0.3951
Open:0.3951
Low:0.3951
Close:0.3951
Loading ...

QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time

Business Wire
·
14 Jan

Qt Imaging Holdings Inc: Forecasts Revenue of $18M in 2025 and $27M in 2026

THOMSON REUTERS
·
13 Jan

QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

Business Wire
·
13 Jan

Qt Imaging Holdings Announces New Commercial Shipment in Partnership With Couri Center

THOMSON REUTERS
·
12 Dec 2024

QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center

Business Wire
·
12 Dec 2024

QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting

Business Wire
·
21 Nov 2024

QT Imaging Q3 EPS $(0.17) Down From $(0.14) YoY; Revenue $956K Up From $25K YoY

Benzinga
·
13 Nov 2024

Press Release: QT Imaging Announces Third Quarter 2024 Financial Results

Dow Jones
·
13 Nov 2024

QT Imaging Holdings Announces $1M Insiders PIPE Investment

Business Wire
·
13 Nov 2024

BRIEF-QT Imaging Holdings, investor enter into second omnibus amendment

Reuters
·
02 Nov 2024

Qt Imaging Holdings Inc: on October 31, Co and Investor Entered Into Second Omnibus Amendment

THOMSON REUTERS
·
02 Nov 2024

Qt Imaging Holdings Inc: Under Amendment, Maturity Date of Investor Note Extended From December 15, 2025 to March 31, 2026

THOMSON REUTERS
·
02 Nov 2024

BRIEF-QT Imaging Granted Renewal Of NIH Sponsored Study For Early Identification Of Response Of Breast Cancer Patients To Neoadjuvant Chemotherapy

Reuters
·
29 Oct 2024

Qt Imaging Granted Renewal of Nih Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

THOMSON REUTERS
·
29 Oct 2024

QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

Business Wire
·
29 Oct 2024

BRIEF-QT Imaging Holdings Announces Favorable Amendment Of Convertible Promissory Note

Reuters
·
30 Sep 2024

Qt Imaging Holdings Inc - Maturity Date of Note Extended to December 15, 2025

THOMSON REUTERS
·
30 Sep 2024

Qt Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note

THOMSON REUTERS
·
30 Sep 2024

Qt Imaging Holdings Inc - Amendment Waives Potential Nasdaq Delisting as Event of Default

THOMSON REUTERS
·
30 Sep 2024

QT Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note

Business Wire
·
30 Sep 2024